Skip to main content
MDxHealth SA logo

MDxHealth SA — Investor Relations & Filings

Ticker · MDXH ISIN · BE0974461940 LEI · 549300J3MG9F9B5FY646 BR Human health and social work activities
Filings indexed 940 across all filing types
Latest filing 2026-04-03 Regulatory Filings
Country BE Belgium
Listing BR MDXH

About MDxHealth SA

https://mdxhealth.com/

MDxHealth SA is a commercial-stage precision diagnostics company that provides actionable molecular information to personalize the diagnosis and treatment of urologic conditions. The company's portfolio of tests is designed to assist clinicians in making more informed decisions. For prostate cancer, its products include Select mdx, which assesses a patient's risk to help determine if a biopsy can be safely avoided; Confirm mdx, which addresses biopsy sampling errors; and the GPS (Genomic Prostate Score) test, a genomic assay that helps guide treatment decisions for men with localized disease. Additionally, the company offers Resolve mdx, a test that aids in selecting appropriate treatment for patients presenting with symptoms of urinary tract infections (UTIs).

Recent filings

Filing Released Lang Actions
S-8 - MDxHealth SA (0001872529) (Filer)
Regulatory Filings
2026-04-03 English
3 - MDxHealth SA (0001872529) (Issuer)
Director's Dealing
2026-03-19 English
6-K Filing
Regulatory Filings
2026-02-11 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-01-16 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2026-01-12 English
REGISTRATION STATEMENT
Regulatory Filings
2025-12-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.